About Us
BIOADVANCE CENTROAMERICA S.A. – BIOADVANCE® is a Costa Rican company specialized in the import and sale of materials, tests and equipment for human and animal laboratory diagnostics, in the Central American region. We serve the public, private and academic sectors.
We began our work in 2011, and since then, we have been in a continuous expansion throughout Central America, acquiring the experience to diversify during this new decade in other areas where we have extensive knowledge and with the support of the great human talent that we have, to be able to develop solutions tailored to our clients.
Our Business Lines
Veterinary Medicine
We offer a wide range of diagnostic solutions, of great help for the practice of Veterinary Medicine, from the simplest screening tests to diagnostic imaging tests.
Social Responsability
Pets Identification
We understand the importance of the correct pets identification, a very important member of each family at a universal level. That is why we offer Microchips and RFID Readers certified by ICAR under the ISO 11784 and ISO 11785 standards.
The latest from our Blog
New strategies needed to control IBD in poultry
Controlling Infectious Bursal Disease virus (IBDv) is key for the future stability of the global poultry industry, according to UK researchers. Scientists from Keele University say new strategies are needed to control the IBDv, which can severely damage the immune...
New vaccine to combat M. bovis in dairy herds
A new live, single-strain vaccine is set to come on the market next year to help dairy and beef farmers in their battle against Mycoplasma bovis (M. bovis). Cited as the most common pathogen in respiratory disease diagnoses, M. bovis is a significant problem facing UK...
How often do you vaccinate for parvo?
A trainer I admire who has a large social media presence asked her followers about how they manage their adult dogs’ vaccinations against parvovirus: Do they vaccinate once a year, once every three years, never, or titer and then decide?I’m pretty sure she specified...